Search Results 171-180 of 14138 for SC

  1. Alumni - Gastrointestinal and Hepatobiliary Pathology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Great Lakes Pathologist S.C., West Allis, WI. 2021, Yaohong Wang, M.D., Ph.D. Vanderbilt University Medical Center, Nashville, TN. 2020, Daniel Rowan, M.D. ...

  2. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

    The purpose of this study is to assess the safety of PH FDC SC when administered at home by an HHNP. Patients will be assessed for safety by regular evaluation ...

  3. Lichen sclerosus - Diagnosis and treatment - Mayo Clinic

    Diagnosis. Your health care provider may diagnose lichen sclerosus by looking at the affected skin. You may need a biopsy to rule out cancer.

  4. C. Diff Infection Risk Rises with Antihistamine Use to Treat Stomach Acid, Mayo Clinic Finds

    diff infections. Co-authors include Imad M. Tleyjeh, M.D., M.Sc.; Muhammad Riaz, M.Sc.; Musa Garbati, M.D.; ...

  5. Romiplostim (subcutaneous route) - Side effects & uses - Mayo Clinic

    Romiplostim injection is used to treat low blood platelet counts (thrombocytopenia) and help prevent bleeding in patients with a blood disorder called immune ...

  6. Publications - Aaron B. Skolnik, M.D. - Mayo Clinic

    Curry SC, Padilla-Jones A, Ruha AM, O'Connor AD, Kang AM, Wilkins DG, Jaeschke H, Wilhelms K, Gerkin RD, Acetaminophen Adduct Study Group. The Relationship ...

  7. Insulin glargine, recombinant (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Solution. Back to top ...

  8. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Liraglutide injection is used with diet and exercise to lower blood sugar in people with type 2 diabetes. It is also used to reduce the risk of life-threatening ...

  9. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Mayo Clinic gastroenterologist Michael Camilleri, M.D., D.Sc., discusses the interplay between gastrointestinal and liver diseases and obesity, and the role ...

  10. Publications - Michael J. Maniaci, M.D. - Mayo Clinic

    ... SC, Habermann EB, Bosch W, Cowart JB, Yao X. Safety in a hybrid hospital-at-home program versus traditional inpatient care: A pragmatic randomized ...